Franklin Resources Inc. Has $8.89 Million Position in DaVita Inc. (NYSE:DVA)

Franklin Resources Inc. increased its holdings in shares of DaVita Inc. (NYSE:DVA) by 134.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 54,901 shares of the company’s stock after purchasing an additional 31,502 shares during the period. Franklin Resources Inc. owned approximately 0.07% of DaVita worth $8,885,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in DVA. Transcendent Capital Group LLC bought a new stake in shares of DaVita in the third quarter valued at about $25,000. Blue Trust Inc. lifted its position in shares of DaVita by 58.6% in the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after acquiring an additional 78 shares during the period. Family Firm Inc. acquired a new stake in shares of DaVita during the 2nd quarter worth approximately $43,000. Quarry LP bought a new stake in shares of DaVita during the third quarter valued at approximately $60,000. Finally, Point72 Hong Kong Ltd acquired a new position in shares of DaVita in the second quarter valued at $68,000. Institutional investors own 90.12% of the company’s stock.

Analyst Ratings Changes

DVA has been the subject of a number of analyst reports. Truist Financial raised their price objective on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th. Barclays raised their price target on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, DaVita currently has a consensus rating of “Hold” and a consensus target price of $161.80.

DaVita Stock Performance

Shares of NYSE:DVA opened at $151.85 on Friday. The business has a fifty day moving average of $157.00 and a 200-day moving average of $150.88. The firm has a market cap of $12.45 billion, a PE ratio of 16.38, a price-to-earnings-growth ratio of 0.86 and a beta of 0.90. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. DaVita Inc. has a twelve month low of $103.40 and a twelve month high of $169.51.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The company had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the prior year, the firm posted $2.85 earnings per share. The company’s revenue was up 4.6% on a year-over-year basis. On average, equities research analysts predict that DaVita Inc. will post 9.71 EPS for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.